πŸ‡ΊπŸ‡Έ FDA
Patent

US 12005123

Conjugate of isotretinoin and peptide

granted A61KA61K2800/522A61K31/19

Quick answer

US patent 12005123 (Conjugate of isotretinoin and peptide) held by CAREGEN CO., LTD. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2800/522, A61K31/19, A61K47/64, A61K8/64